PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CALCIPENIA

摘要

It is intended to develop an agent having at least one of anti-calcipenia, antiedemic and diuretic activities for human or animals and to inhibit any postpartum drop of the calcium concentration in blood, thereby maintaining the health of mother body and smoothing nursing and lactation. Difructose anhydride (DFA) being a disaccharide consisting of two molecules of fructose coupled together is administered. In particular, for inhibiting any postpartum drop of the calcium concentration in blood, DFA III and/or DFA IV is administered before childbirth delivery (in cases of cow, before expected date of confinement). If desired, joint use of a calcium agent or vitamin D can be made.